INTERNATIONAL PATENT: ARGENX BV FILES APPLICATION FOR "METHODS OF DETERMINING POTENCY OF A HUMAN NEONATAL FC RECEPTOR ANTAGONIST"

GENEVA, June 16 -- ARGENX BV (Industriepark-zwijnaarde 79052 Ghent (zwijnaarde)) filed a patent application (PCT/IB2024/000716) for "METHODS OF DETERMINING POTENCY OF A HUMAN NEONATAL FC RECEPTOR ANTAGONIST" on Dec 04, 2024. With publication no. WO/2025/120373, the details related to the patent application was published on Jun 12, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BORGIONS, Filip (C/o Argenx BvIndustriepark-zwijnaarde 79052 Ghent (zwijnaarde)), HANSSENS, Valerie (C/o Argenx BvIndustriepark-zwijnaarde 79052 Ghent (zwijnaarde))

Abstract: Methods of determining the potency of a...